Rituximab and Omalizumab for the Treatment of Bullous Pemphigoid: A Systematic Review of the Literature

Biological and Clinical Response to Omalizumab in a Patient with Bullous Pemphigoid

(2018) S Menzinger et al.   ACTA DERMATO-VENEREOLOGICA

Treatment and retreatment with omalizumab in chronic spontaneous urticaria: Real life experience with twenty-five patients

(2018) Murat Türk et al.   ALLERGOLOGY INTERNATIONAL

Omalizumab for the Treatment of Solar Urticaria: Case Series and Systematic Review of the Literature

(2018) Igor Snast et al.   Journal of Allergy and Clinical Immunology-In Practice

Our clinical experience with the use of omalizumab in the treatment of bullous pemphigoid

(2017) Pınar İncel Uysal et al.   TURKDERM-ARCHIVES OF THE TURKISH DERMATOLOGY AND VENEROLOGY

Clinical efficacy of omalizumab in chronic spontaneous urticaria is associated with a reduction of FcεRI-positive cells in the skin

(2017) Martin Metz et al.   Theranostics

Rituximab Treatment of Nivolumab-Induced Bullous Pemphigoid

(2017) Laura Sowerby et al.   JAMA Dermatology

Correlation of Serum Levels of IgE Autoantibodies Against BP180 With Bullous Pemphigoid Disease Activity

(2017) Nina van Beek et al.   JAMA Dermatology

Bullous pemphigoid successfully treated with omalizumab

(2016) Müzeyyen Gönül et al.   Indian Journal of Dermatology Venereology & Leprology

Treatment of recalcitrant bullous pemphigoid (BP) with a novel protocol: A retrospective study with a 6-year follow-up

(2016) A. Razzaque Ahmed et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Successful treatment of bullous pemphigoid with omalizumab as corticosteroid-sparing agent: report of two cases and review of literature

(2016) G. Balakirski et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Rituximab in patients with recalcitrant autoimmune blistering diseases: experience in a cohort of 22 patients

(2015) D. Tomsitz et al.   BRITISH JOURNAL OF DERMATOLOGY

First-line combination therapy with rituximab and corticosteroids provides a high complete remission rate in moderate-to-severe bullous pemphigoid

(2015) Y.T. Cho et al.   BRITISH JOURNAL OF DERMATOLOGY

Management of bullous pemphigoid: the European Dermatology Forum consensus in collaboration with the European Academy of Dermatology and Venereology

(2015) C. Feliciani et al.   BRITISH JOURNAL OF DERMATOLOGY

Possible paraneoplastic syndrome case of bullous pemphigoid with immunoglobulin G anti-BP180 C-terminal domain antibodies associated with psoriasis and primary macroglobulinemia

(2015) Nobuki Maki et al.   JOURNAL OF DERMATOLOGY

Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria Who Remain Symptomatic on H 1 Antihistamines: A Randomized, Placebo-Controlled Study

(2015) Sarbjit S. Saini et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Remission Time after Rituximab Treatment for Autoimmune Bullous Disease: A Proposed Update Definition

(2015) Pilar Iranzo et al.   SKIN PHARMACOLOGY AND PHYSIOLOGY

Bullous Pemphigoid Associated with Acquired Hemophilia A: A Rare Association of Autoimmune Disease

(2015) Mohammed I. AlJasser et al.   JOURNAL OF CUTANEOUS MEDICINE AND SURGERY

Remission of Bullous Pemphigoid after Rituximab Treatment in a Psoriasis Patient on Regular Low-dose Methotrexate

(2014) T Wang et al.   ACTA DERMATO-VENEREOLOGICA

Omalizumab therapy for bullous pemphigoid

(2014) Kenneth K. Yu et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Refractory bullous pemphigoid with fatal outcome in a young patient

(2013) Maria João Cruz et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Association of Serum B-Cell Activating Factor Level and Proportion of Memory and Transitional B Cells with Clinical Response after Rituximab Treatment of Bullous Pemphigoid Patients

(2013) Russell P. Hall et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Treatment of severe autoimmune blistering skin diseases with combination of protein A immunoadsorption and rituximab: a protocol without initial high dose or pulse steroid medication

(2013) M. Kolesnik et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Successful Treatment of Bullous Pemphigoid With Omalizumab

(2012) Vanessa A. London et al.   ARCHIVES OF DERMATOLOGY

British Association of Dermatologists’ guidelines for the management of bullous pemphigoid 2012

(2012) V.A. Venning et al.   BRITISH JOURNAL OF DERMATOLOGY

Corticosteroid Use in Autoimmune Blistering Diseases

(2012) John W. Frew et al.   IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA

Refractory Childhood Pemphigoid Successfully Treated with Rituximab

(2012) Irene Fuertes et al.   PEDIATRIC DERMATOLOGY

Successful management of severe infant bullous pemphigoid with omalizumab

(2011) C. Dufour et al.   BRITISH JOURNAL OF DERMATOLOGY

Rituximab for treatment-refractory pemphigus and pemphigoid: A case series of 17 patients

(2011) Michael Kasperkiewicz et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Definitions and outcome measures for bullous pemphigoid: Recommendations by an international panel of experts

(2011) Dedee F. Murrell et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Bullous and mucous membrane pemphigoid show a mixed response to rituximab: experience in seven patients

(2010) S. Lourari et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Risk Factors for Relapse in Patients With Bullous Pemphigoid in Clinical Remission

(2009) Philippe Bernard et al.   ARCHIVES OF DERMATOLOGY

Pathogenicity of IgE in autoimmunity: Successful treatment of bullous pemphigoid with omalizumab

(2009) Janet A. Fairley et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE

Severe Bullous Pemphigoid in an Infant- Successful Treatment with Rituximab

(2008) Johannes Schulze et al.   PEDIATRIC DERMATOLOGY

A biological approach in a patient with psoriasis and bullous pemphigoid associated with losartan therapy

(2007) R. Saraceno et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY